ProShare Advisors’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $186K | Buy |
|
|||||
|
2024
Q3 | $37.1K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $39K | Buy |
|
|||||
|
2023
Q4 | $37.8K | Sell |
|
|||||
|
2023
Q3 | $34.5K | Buy |
|
|||||
|
2023
Q2 | $25.4K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $53K | Sell |
|
|||||
|
2021
Q4 | $103K | Sell |
|
|||||
|
2021
Q3 | $124K | Sell |
|
|||||
|
2021
Q2 | $187K | Buy |
|
|||||
|
2021
Q1 | $166K | Buy |
|
|||||
|
2020
Q4 | $137K | Buy |
|